Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2b Monotherapy Study of ABT-263 in Subjects With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia

NCT00918450 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00918450
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00918450 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2b Monotherapy Study of ABT-263 in Subjects With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
Lead sponsor
Abbott
Phase
Phase 2
Overall status
Withdrawn
Start date
March 31, 2010
Completion date
Not reported
Enrollment
150 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

b-cell chronic lymphocytic leukemia